Metformin may help improve adiposopathic disorders:
Insulin resistance
Polycystic ovary syndrome
Cardiovascular disease (especially when compared to sulfonylurea)
May help treat complications of concurrent drug treatments:
Antipsychotic-related weight gain
Human immunodeficiency virus (HIV) protease inhibitor-associated abnormalities (i.e., HIV lipodystrophy)
Metformin may help reduce the overall cancer rate and help improve the treatment of multiple cancers:
Colon cancer
Ovary cancer
Lung cancer
Breast cancer
Prostate cancer
Metformin may improve insulin sensitivity and reduce hunger via multifactorial effects such as enhancing the effects of gastrointestinal hormones applicable to weight loss (e.g., increased glucagon-like peptide-1 levels and receptors, increased peptide YY, decreased neuropeptide Y) all which may facilitate long-term weight loss